Trial intelligence / Profile preview

Chai Ge Tuire Oral Liquid for Acute Upper Respiratory Tract Infection (Common Cold, Wind-Heat Pattern)

CTR20251047Phase 3Completed

Sponsor
Shanghai Yuzhihua Pharmaceutical Technology
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Chaige Tuire oral liquid in upper respiratory infection (URI), sponsored by Shanghai Yuzhihua Pharmaceutical Technology. Started Mar 2025; status: completed.

02

Drugs

Chaige Tuire oral liquid
03

Conditions

upper respiratory infection (URI)

Beyond the preview

Go deeper on CTR20251047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20251047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call